The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection

Introduction: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice. Methods: A retrospective cha...

Full description

Bibliographic Details
Published in:Mental Health Clinician
Main Authors: Trevor A. Stump, PharmD, BCPP, Leigh Anne Nelson, PharmD, BCPP, Yifei Liu, BS Pharm, PhD, Carrie R. Kriz, MS, Courtney A. Iuppa, PharmD, BCPP, Lauren A. Diefenderfer, PharmD, BCPP, Shelby E. Lang, PharmD, BCPP, Ellie S. R. Elliot, PharmD, BCPP, Roger W. Sommi, PharmD, BCPP, FCCP
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2021-01-01
Subjects:
paliperidone palmitate
long-acting injectable antipsychotic
oral antipsychotic overlap
benztropine
adverse events
decompensation
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2021.01.012

Internet

https://theijpt.org/doi/pdf/10.9740/mhc.2021.01.012

Similar Items